Hayley Wilson
thehjbrod.bsky.social
Hayley Wilson
@thehjbrod.bsky.social
Policy analyst (biomedical science) at PHG Foundation. Research interests include pathogen genomics, AMR, genomic medicine and closing research to implementation gaps.
Reposted by Hayley Wilson
​PHG Senior policy analyst, Dr Chantal Babb de Villiers talks about her work beyond PHG Foundation (how does she fit it all in!🌟), in South Africa where she has been supporting efforts to increase diversity of global genomic data.
How do you take scientific research from the lab and deliver it to patients?🔬

Recent Hughes Fellow, Dr Chantal Babb de Villiers, talks about bridging academic research, clinical care, public health, and her work with the @phgfoundation.bsky.social.🩺

youtu.be/uPkqXpZLOv0?...
@cam.ac.uk
Dr Chantal Babb de Villiers
Research Stories: Remarkable people, groundbreaking work, global impact. In this series, our researchers talk about their work and the difference it is making around the world, from tackling climate…
youtu.be
October 16, 2025 at 12:22 PM
PHG Foundation is hosting its first Bradford Hill Seminar for a few years. Come and join us online or in person if you have an interest in early detection and cancer diagnostics.
Join us for the next Bradford Hill Seminar.

We’re pleased to host Professor James Flanagan, Professor of Cancer Informatics at Imperial College London, who will speak on:

"The Cancer Loyalty Card Study (CLOCS), aiming to help reduce the delays in cancer diagnosis using transaction data"
June 11, 2025 at 2:25 PM
Reposted by Hayley Wilson
Date: Wednesday 2 July 2025

Time: 13:00 - 14:00

In-person: Large Seminar Room, East Forvie Building, Robinson Way, Cambridge CB2 0SR (No registration required)

Online: Register here: events.teams.microsoft.com/event/9d02ab...
June 9, 2025 at 10:39 AM
I'm really excited to share the postdoc I completed before joining PHG. It combines two great passions - bacteria and horses!!

Read more here: www.linkedin.com/posts/hayley... or go straight to the paper here: www.microbiologyresearch.org/content/jour...
Progressive evolution of Streptococcus equi from Streptococcus equi subsp.… | Hayley Wilson
I'm really excited to share this work with the world! As we know, academic research work will follow you even after you've left. So this is my post-doc project…
www.linkedin.com
March 31, 2025 at 10:35 AM
Reposted by Hayley Wilson
🌟 New Blog🌟
Pharmacogenomics is leading the way in how genomic information is being used in healthcare and could significantly impact how genomics is integrated across the entire healthcare system. www.phgfoundation.org/blog/pioneer...
Pioneering change: how pharmacogenomics is shaping healthcare - PHG Foundation
Pharmacogenomics - tailoring drug treatments to individuals based on their genetics - is on the cusp of transforming drug prescribing
www.phgfoundation.org
February 10, 2025 at 2:56 PM
Reposted by Hayley Wilson
Read this👇
A long post about what’s happening to the science funding agencies in the US and why. As mentioned, this one just kept getting longer even as I kept stripping curse words from it.

www.science.org/content/blog...
What's Happening Inside the NIH and NSF
www.science.org
February 5, 2025 at 11:47 AM
Reposted by Hayley Wilson
Exciting News in Gene Therapy! 
NICE has approved the use of gene therapy exa-cel for treating sickle cell disease! This groundbreaking development offers new hope for patients and marks a significant milestone in medical science. 🧬✨
www.phgfoundation.org/news/worlds-...
World’s first gene editing therapy now in the UK for sickle cell disease - PHG Foundation
The approval by NICE of Exa-cel provides new hope for people living with sickle cell disease.
www.phgfoundation.org
February 3, 2025 at 3:54 PM
Reposted by Hayley Wilson
⚠️ Bit of an alarm bell to MDR-TB regimen BPaL/M - resistance to constituent antibiotics developing and transmission of such strains already occurring
#TBSky #IDSky @nejm.org

www.nejm.org/doi/10.1056/...
Transmission as a Key Driver of Resistance to the New Tuberculosis Drugs | NEJM
Whole-genome sequencing was used to show that resistance to newer antituberculosis drugs is present in at least 27 countries and that up to a quarter of this resistance may be due to person-to-...
www.nejm.org
January 5, 2025 at 7:57 AM
I made it over here! It’s nice to step away from the absolute carnage of the other platform. There’s real science in here!!!
October 12, 2023 at 10:46 AM